PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
11.01%
Net income growth under 50% of CRWD's 101.02%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
1.21%
Less D&A growth vs. CRWD's 9.81%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
69.92%
Well above CRWD's 73.98% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
3.77%
SBC growth while CRWD is negative at -14.11%. John Neff would see competitor possibly controlling share issuance more tightly.
-43.01%
Both reduce yoy usage, with CRWD at -8.49%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
198.13%
AR growth well above CRWD's 217.19%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-235.03%
Negative yoy inventory while CRWD is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-7.40%
Negative yoy AP while CRWD is 54.05%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-167.56%
Both reduce yoy usage, with CRWD at -124.72%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-68.18%
Negative yoy while CRWD is 6.53%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
6.30%
Operating cash flow growth at 50-75% of CRWD's 10.10%. Martin Whitman would worry about lagging operational liquidity vs. competitor.
-10.89%
Both yoy lines negative, with CRWD at -11.89%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-247.80%
Negative yoy acquisition while CRWD stands at 9380.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
29.36%
Less growth in investment purchases vs. CRWD's 95.74%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
69.81%
Below 50% of CRWD's 388.31%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
-265.06%
We reduce yoy other investing while CRWD is 64.51%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
105.51%
Investing outflow well above CRWD's 120.69%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-50.00%
We cut debt repayment yoy while CRWD is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
33.79%
We slightly raise equity while CRWD is negative at -90.27%. John Neff sees competitor possibly preserving share count or buying back shares.
15.31%
We have some buyback growth while CRWD is negative at -100.00%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.